Skip to main content
Premium Trial:

Request an Annual Quote

Acacia s Two New Stocks Begin Life on Nasdaq

NEW YORK, Dec. 17 - Fulfilling a promise made last March, Acacia Research today said its two new classes of common stock--Acacia Research/CombiMatrix and Acacia Research/Acacia Technologies--have begun trading on the Nasdaq exchange.


Acacia created the classes as part of a recapitalization that had been approved by company stockholders in May. The two stocks replace Acacia's one common stock that formerly traded on the Nasdaq under the symbol ACRI.


According to Acacia, Acacia Research/CombiMatrix stock, which will trade under the ticker CBMX, will reflect the performance of its CombiMatrix subsidiary. The Acacia Research/Acacia Technologies stock, which will trade as ACTG, will follow Acacia Research's media-technology businesses.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.